Starting late June, a groundbreaking blood test designed to diagnose Alzheimer’s disease will be available in the U.S., offering a faster and more cost-effective alternative to traditional methods. This innovation could revolutionize Alzheimer’s treatment and improve patient outcomes!
A new study reveals that prolonged sitting can harm your brain, even if you exercise regularly. Discover how sitting impacts memory and brain health, especially for those at genetic risk.
New research reveals that HIV drugs known as NRTIs can reduce the risk of developing Alzheimer’s disease by 6% to 13% annually. Scientists urge for clinical trials to explore this promising link.
A new blood test developed by neuroscientists can reveal whether Alzheimer's is affecting a patient's memory, providing crucial insights for early diagnosis and treatment. This innovation could transform how we understand and address Alzheimer's disease.
Discover the inspiring journeys of Kaileigh Baia and Jennifer Gansler as they navigate the challenges of long COVID. Their experiences shed light on the lasting impacts of the virus and the path to recovery.
A groundbreaking study from Washington University reveals that new Alzheimer’s medications could extend patient independence by up to 13 months. Discover how these findings reshape treatment decisions.
Study shows that new Alzheimer's drugs lecanemab and donanemab can significantly extend the period of independent living for patients with early-stage Alzheimer's disease, highlighting potential benefits and risks.
A recent study reveals that common antidepressants prescribed to dementia patients could be accelerating cognitive decline and increasing the risk of fractures and mortality. Find out the shocking implications for dementia care.
